Rybrevant requires prior authorization for dates of service on or after Sept. 27 for most members

For dates of service on or after Sept. 27, 2021, Rybrevant (amivantamab-vmjw), HCPCS codes J9999, J3490, J3590 and C9399, will require prior authorization through AIM Specialty Health®. This drug is covered under the medical benefit.

Prior authorization requirements apply when this drug is administered in outpatient settings for:

  • Blue Cross and Blue Shield of Michigan commercial members who have coverage through fully insured groups and who have individual coverage

    Exceptions: This requirement doesn't apply to Michigan Education Special Services Association members or members who have coverage through the Michigan Blue Cross and Blue Shield Federal Employee Program®. This requirement also doesn't apply to UAW Retiree Medical Benefits Trust PPO non-Medicare members and other members with coverage through self-funded groups.

  • Medicare Plus BlueSM members
  • Blue Care Network commercial members
  • BCN AdvantageSM members

How to submit authorization requests

Submit authorization requests to AIM using one of the following methods:

More about the authorization requirements

Authorization isn't a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for members.

For additional information on requirements related to drugs covered under the medical benefit, see:

We'll update the appropriate drug lists to reflect the information in this message prior to the effective date.

*Clicking this link means that you're leaving the Blue Cross Blue Shield of Michigan and Blue Care Network website. While we recommend this site, we're not responsible for its content.

Posted: July 2021
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network